Your browser doesn't support javascript.
loading
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.
Albanell, J; González, A; Ruiz-Borrego, M; Alba, E; García-Saenz, J A; Corominas, J M; Burgues, O; Furio, V; Rojo, A; Palacios, J; Bermejo, B; Martínez-García, M; Limon, M L; Muñoz, A S; Martín, M; Tusquets, I; Rojo, F; Colomer, R; Faull, I; Lluch, A.
  • Albanell J; Medical Oncology Service, Hospital del Mar, Barcelona; Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona; Department of Medicine, Autonomous University of Barcelona, Barcelona. Electronic address: jalbanell@hospitaldelmar.cat.
  • González A; Medical Oncology Service, MD Anderson, Madrid.
  • Ruiz-Borrego M; Medical Oncology Service, Hospital Virgen del Rocío, Sevilla.
  • Alba E; Medical Oncology Service, Hospital Virgen de la Victoria, Málaga.
  • García-Saenz JA; Medical Oncology Service, Hospital Clínico, Madrid.
  • Corominas JM; Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona; Department of Medicine, Autonomous University of Barcelona, Barcelona; Pathology Service, Hospital del Mar, Barcelona.
  • Burgues O; Pathology Service, Hospital Clínico, Valencia.
  • Furio V; Pathology Service, Hospital Clínico, Madrid.
  • Rojo A; Pathology Service, MD Anderson, Madrid.
  • Palacios J; Pathology Service, Hospital Virgen del Rocío, Sevilla.
  • Bermejo B; Department of Hematology and Oncology, Hospital Clínico de Valencia, Valencia.
  • Martínez-García M; Medical Oncology Service, Hospital del Mar, Barcelona; Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona.
  • Limon ML; Medical Oncology Service, Hospital Virgen del Rocío, Sevilla.
  • Muñoz AS; Medical Oncology Service, Hospital Virgen de la Victoria, Málaga.
  • Martín M; Medical Oncology Service, Hospital Gregorio Marañón Madrid, Madrid.
  • Tusquets I; Medical Oncology Service, Hospital del Mar, Barcelona; Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona.
  • Rojo F; Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona; Pathology Service, Fundación Jiménez Díaz, Madrid.
  • Colomer R; Medical Oncology Service, MD Anderson, Madrid.
  • Faull I; LiveMedix, Barcelona, Spain.
  • Lluch A; Department of Hematology and Oncology, Hospital Clínico de Valencia, Valencia.
Ann Oncol ; 23(3): 625-631, 2012 Mar.
Article en En | MEDLINE | ID: mdl-21652577
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Neoplasias de la Mama Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Año: 2012 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Neoplasias de la Mama Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Año: 2012 Tipo del documento: Article